Immunotherapy & Immuno-Oncology
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.6t | $238.49 | -0.7% | 6.5M |
 ABBV | ABBVIE INC. | $377.0b | $208.44 | -0.9% | 6.0M |
 AZN | AstraZeneca PLC | $300.7b | $201.21 | -1.6% | 1.7M |
 MRK | Merck & Co., Inc. | $292.0b | $117.76 | -1.8% | 7.7M |
 AMGN | Amgen Inc | $188.1b | $348.13 | -0.8% | 2.1M |
 BMY | Bristol-Myers Squibb Co. | $122.0b | $57.90 | -0.3% | 8.7M |
 REGN | Regeneron Pharmaceuticals Inc | $79.2b | $753.75 | -0.2% | 570.9K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $19.9b | $48.70 | -0.2% | 1.9M |
 MRNA | Moderna, Inc. Common Stock | $19.1b | $54.21 | +2.6% | 4.8M |
 IBRX | ImmunityBio, Inc. Common Stock | $6.8b | $7.80 | +2.6% | 10.5M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $114.98 | +0.1% | 588.9K |
 CGON | CG Oncology, Inc. Common stock | $5.4b | $67.67 | +0.6% | 1.2M |
 RCUS | Arcus Biosciences, Inc. | $2.6b | $23.70 | +3.0% | 1.0M |
 SNDX | Syndax Pharmaceuticals, Inc. | $2.0b | $24.33 | -0.4% | 1.5M |
 NKTR | Nektar Therapeutics | $1.9b | $83.23 | +2.4% | 528.8K |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.83 | +5.2% | 12.2M |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $10.99 | +0.4% | 322.2K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.2b | $23.71 | +3.2% | 736.8K |
 PGEN | Precigen, Inc. Common Stock | $1.2b | $3.89 | -2.3% | 2.7M |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.1b | $15.11 | -0.9% | 961.9K |
 CTMX | CytomX Therapeutics, Inc. | $1.0b | $4.55 | +0.3% | 4.7M |
 CMPX | Compass Therapeutics, Inc. Common Stock | $0.9b | $5.84 | +7.4% | 3.2M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $0.9b | $83.83 | +0.8% | 263.9K |
 XNCR | Xencor, Inc. | $0.8b | $12.51 | 0.0% | 978.3K |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $0.8b | $14.95 | +4.1% | 977.9K |
 JANX | Janux Therapeutics, Inc. Common Stock | $0.8b | $15.03 | -1.4% | 987.6K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $0.7b | $4.89 | +0.6% | 2.7M |
 OMER | Omeros Corporation | $0.7b | $12.25 | +3.5% | 1.2M |
 REPL | Replimune Group, Inc. | $0.6b | $2.30 | +17.9% | 12.8M |
 CBIO | Crescent Biopharma, Inc. Common Stock | $0.5b | $19.98 | +2.4% | 229.3K |
 AURA | Aura Biosciences, Inc. Common Stock | $394.2m | $7.09 | 0.0% | 325.5K |
 CADL | Candel Therapeutics, Inc. Common Stock | $328.1m | $5.14 | +0.8% | 1.0M |
 GLSI | Greenwich LifeSciences, Inc. | $297.7m | $25.99 | -0.1% | 81.2K |
 ALXO | ALX Oncology Holdings Inc. Common Stock | $251.4m | $1.68 | +4.0% | 1.1M |
 CHRS | Coherus Oncology, Inc. Common Stock | $239.8m | $1.88 | +4.4% | 1.1M |
 CNTX | Context Therapeutics Inc. Common Stock | $225.1m | $2.51 | 0.0% | 936.8K |
 CGEN | Compugen Ltd | $188.2m | $2.90 | +0.7% | 672.7K |
 ELTX | Elicio Therapeutics, Inc. Common Stock | $185.4m | $11.83 | +0.9% | 76.0K |
 MGNX | MacroGenics, Inc. | $175.4m | $3.52 | +0.9% | 649.8K |
 AGEN | Agenus Inc. | $124.4m | $4.82 | +2.1% | 1.5M |
 GNLX | Genelux Corporation Common Stock | $103.1m | $2.83 | +7.4% | 404.3K |
 HURA | TuHURA Biosciences, Inc. Common Stock | $97.7m | $3.08 | -2.2% | 1.9M |
 ONCY | Oncolytics Biotech, Inc. Common Shares | $86.6m | $1.08 | +6.4% | 1.3M |
 ANIX | Anixa Biosciences, Inc. | $83.8m | $2.90 | +0.9% | 93.1K |
 MAIA | MAIA Biotechnology, Inc. | $79.5m | $1.47 | +7.3% | 777.5K |
 XBIT | XBiotech Inc | $69.2m | $2.46 | +1.2% | 6.4K |
 BYSI | BeyondSpring Inc. Ordinary Shares | $66.6m | $1.73 | 0.0% | 2.4K |
 IBO | Impact BioMedical, Inc. | $63.1m | $0.64 | -2.8% | 56.1K |
 TIL | Instil Bio, Inc. Common Stock | $54.1m | $8.83 | +4.6% | 81.9K |
 XLO | Xilio Therapeutics, Inc. Common Stock | $47.6m | $8.59 | 0.0% | 36.1K |